5-Bromo-1-(1,2,4-oxadiazol-3-ylmethyl)-2,3-dihydro-1H-indole-2,3-dione

Catalog No. :
ACEZCF554
CAS No. :
1042633-64-6
Molecular Formula :
C11H6BrN3O3
Molecular Weight :
308.09

IUPAC Name:1-((1,2,4-oxadiazol-3-yl)methyl)-5-bromoindoline-2,3-dione

5-Bromo-1-(1,2,4-oxadiazol-3-ylmethyl)-2,3-dihydro-1H-indole-2,3-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$236.00Login to see priceInquiryInquiry
100mg95%$340.00Login to see priceInquiryInquiry
250mg95%$477.00Login to see priceInquiryInquiry
1g95%$948.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-1-(1,2,4-oxadiazol-3-ylmethyl)-2,3-dihydro-1H-indole-2,3-dione
IUPAC Name1-((1,2,4-oxadiazol-3-yl)methyl)-5-bromoindoline-2,3-dione
MDL No.MFCD11538287
Molecular FormulaC11H6BrN3O3
Molecular Weight308.09
SMILESO=C1N(CC2=NOC=N2)C3=C(C=C(Br)C=C3)C1=O
InChI KeyJVRRUXPWYUPVTN-UHFFFAOYSA-N
Synonym5-bromo-1-(1,2,4-oxadiazol-3-ylmethyl)-2,3-dihydro-1H-indole-2,3-dione
CAS No.1042633-64-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACEZCF554 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVRDE716 route compound structure diagram
    ACVRDE71687-48-9 In Stock
  4. Then
  5. ACEZCF554 route product structure diagram
    ACEZCF5541042633-64-6
Inquiry

2. ACEZCF554 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACODUI542 route compound structure diagram
    ACODUI54251791-12-9 In Stock
  2. Plus
  3. ACVRDE716 route compound structure diagram
    ACVRDE71687-48-9 In Stock
  4. Then
  5. ACEZCF554 route product structure diagram
    ACEZCF5541042633-64-6
Inquiry

Comments (0)